|
DLAT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.67179611768142E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40510003632244E-09 |
| Normal-vs-Stage2 |
6.306200E-02 |
| Normal-vs-Stage3 |
9.83380000000311E-05 |
| Normal-vs-Stage4 |
2.35970000206365E-08 |
| Stage1-vs-Stage2 |
3.035200E-01 |
| Stage1-vs-Stage3 |
5.590800E-01 |
| Stage1-vs-Stage4 |
1.839000E-01 |
| Stage2-vs-Stage3 |
2.561600E-01 |
| Stage2-vs-Stage4 |
4.923800E-02 |
| Stage3-vs-Stage4 |
3.913800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.37110364465343E-11 |
| Normal-vs-AfricanAmerican |
4.07000000035573E-07 |
| Normal-vs-Asian |
4.33650000020158E-07 |
| Caucasian-vs-AfricanAmerican |
8.266600E-01 |
| Caucasian-vs-Asian |
2.126200E-01 |
| AfricanAmerican-vs-Asian |
1.754790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.8279600883252E-12 |
| Normal-vs-Female |
5.60899999999531E-05 |
| Male-vs-Female |
5.045600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66139999999704E-05 |
| Normal-vs-Extreme_Weight |
7.8218986843126E-11 |
| Normal-vs-Obese |
2.47390000041037E-07 |
| Normal-vs-Extreme_Obese |
2.725000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.900800E-01 |
| Normal_Weight-vs-Obese |
4.313000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.955400E-01 |
| Extreme_Weight-vs-Obese |
2.576200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.661000E-01 |
| Obese-vs-Extreme_Obese |
6.888000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.974100E-04 |
| Normal-vs-Age(41-60Yrs) |
4.80590012230664E-10 |
| Normal-vs-Age(61-80Yrs) |
4.50519954675599E-10 |
| Normal-vs-Age(81-100Yrs) |
5.839500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.011000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.096800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.468200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.170400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.558600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.615400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.39652742095586E-12 |
| Normal-VS-Type2 PRCC |
8.48280000000923E-05 |
| Normal-VS-KIRP CIMP |
2.08120000000367E-06 |
| Normal-VS-Unclassified PRCC |
3.679100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.729600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.653400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.484200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.299600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.269200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.923850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.02540000221663E-08 |
| Normal-vs-N1 |
5.70959945989102E-10 |
| Normal-vs-N2 |
3.41200000475439E-08 |
| N0-vs-N1 |
2.627200E-01 |
| N0-vs-N2 |
8.670100E-02 |
| N1-vs-N2 |
1.259840E-01 |
|
|